CDKN1B and glioblastoma: It also stimulates transcription of cell division cycle 20 (CDC20) through H3R2 me2a, which may facilitate ubiquitination and degradation of cyclin-dependent kinase inhibitor 1B (CDKN1B), thereby promoting GBM cell proliferation [195, 196].